{"id":72653,"date":"2019-11-18T14:37:49","date_gmt":"2019-11-18T13:37:49","guid":{"rendered":"https:\/\/pga-ip.com\/?p=72653"},"modified":"2019-11-18T14:37:49","modified_gmt":"2019-11-18T13:37:49","slug":"la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions","status":"publish","type":"post","link":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/","title":{"rendered":"Dr. Cristaldi from PGA speaks at the conference &#8220;Overview on patentability requirements of pharma inventions&#8221;"},"content":{"rendered":"<p>On October 2nd 2019, at the headquarters of Italian Industrial Property Consultants Institute, in MILAN, a conference was held entitled: <strong>&#8220;Overview on World Wide patentability requirements of pharma inventions &#8211; with special focus on India Patent Law&#8221;<\/strong>.<\/p>\n<p>The conference was organized by a team of consultants specialized in chemical and pharma inventions (CFB group). This group conducted a survey in early 2019 with the aim of gathering information from local correspondents in the major countries of strategic interest for the pharmaceutical sector, concerning the requirements relating to the sufficiency of disclosure of pharmaceutical inventions.<\/p>\n<p>The results of the survey were the subject of a presentation held by Fiorella Cristaldi.<\/p>","protected":false},"excerpt":{"rendered":"<p>On October 2nd 2019, at the headquarters of Italian Industrial Property Consultants Institute, in MILAN, a conference was held entitled: &#8220;Overview on World Wide patentability requirements of pharma inventions &#8211; with special focus on India Patent Law&#8221;. The conference was organized by a team of consultants specialized in chemical and pharma inventions (CFB group). This [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":72654,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57],"tags":[],"class_list":["post-72653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dr. Cristaldi from PGA speaks at the conference &quot;Overview on patentability requirements of pharma inventions&quot; - PGA Intellectual Property - Patents, Trademarks &amp; Designs<\/title>\n<meta name=\"description\" content=\"Il 2 ottobre 2019, presso la sede dell&#039;Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: &quot;Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Dr.ssa Cristaldi di PGA interviene al convegno &quot;Overview on patentability requirements of pharma inventions&quot;\" \/>\n<meta property=\"og:description\" content=\"Il 2 ottobre 2019, presso la sede dell&#039;Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: &quot;Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/\" \/>\n<meta property=\"og:site_name\" content=\"PGA Intellectual Property - Patents, Trademarks &amp; Designs\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-18T13:37:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/La-Dr.ssa-Cristaldi-di-PGA-interviene-al-convegno-Overview-on-patentability-requirements-of-pharma-inventions.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"PGA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"La Dr.ssa Cristaldi di PGA interviene al convegno &quot;Overview on patentability requirements of pharma inventions&quot;\" \/>\n<meta name=\"twitter:description\" content=\"Il 2 ottobre 2019, presso la sede dell&#039;Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: &quot;Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law&quot;.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/La-Dr.ssa-Cristaldi-di-PGA-interviene-al-convegno-Overview-on-patentability-requirements-of-pharma-inventions.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"PGA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/\",\"url\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/\",\"name\":\"[:it]La Dr.ssa Cristaldi di PGA interviene al convegno \\\"Overview on patentability requirements of pharma inventions\\\"[:en]Dr. Cristaldi from PGA speaks at the conference \\\"Overview on patentability requirements of pharma inventions\\\"[:] - PGA Intellectual Property - Patents, Trademarks &amp; Designs\",\"isPartOf\":{\"@id\":\"https:\/\/pga-ip.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg\",\"datePublished\":\"2019-11-18T13:37:49+00:00\",\"author\":{\"@id\":\"https:\/\/pga-ip.com\/#\/schema\/person\/b4d457f38b2d14ac039d12aebbcf73a7\"},\"description\":\"Il 2 ottobre 2019, presso la sede dell'Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: \\\"Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage\",\"url\":\"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg\",\"contentUrl\":\"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pga-ip.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Cristaldi from PGA speaks at the conference &#8220;Overview on patentability requirements of pharma inventions&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pga-ip.com\/#website\",\"url\":\"https:\/\/pga-ip.com\/\",\"name\":\"PGA Intellectual Property - Patents, Trademarks &amp; Designs\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pga-ip.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pga-ip.com\/#\/schema\/person\/b4d457f38b2d14ac039d12aebbcf73a7\",\"name\":\"PGA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pga-ip.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ca59aaf858c703dba8561c87a406e7dd25e9a31bd6d06a1de9ce919401cae3c4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ca59aaf858c703dba8561c87a406e7dd25e9a31bd6d06a1de9ce919401cae3c4?s=96&d=mm&r=g\",\"caption\":\"PGA\"},\"url\":\"https:\/\/pga-ip.com\/en\/author\/pga\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:it]La Dr.ssa Cristaldi di PGA interviene al convegno \"Overview on patentability requirements of pharma inventions\"[:en]Dr. Cristaldi from PGA speaks at the conference \"Overview on patentability requirements of pharma inventions\"[:] - PGA Intellectual Property - Patents, Trademarks &amp; Designs","description":"Il 2 ottobre 2019, presso la sede dell'Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: \"Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/","og_locale":"en_US","og_type":"article","og_title":"La Dr.ssa Cristaldi di PGA interviene al convegno \"Overview on patentability requirements of pharma inventions\"","og_description":"Il 2 ottobre 2019, presso la sede dell'Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: \"Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law\".","og_url":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/","og_site_name":"PGA Intellectual Property - Patents, Trademarks &amp; Designs","article_published_time":"2019-11-18T13:37:49+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/La-Dr.ssa-Cristaldi-di-PGA-interviene-al-convegno-Overview-on-patentability-requirements-of-pharma-inventions.jpg","type":"image\/jpeg"}],"author":"PGA","twitter_card":"summary_large_image","twitter_title":"La Dr.ssa Cristaldi di PGA interviene al convegno \"Overview on patentability requirements of pharma inventions\"","twitter_description":"Il 2 ottobre 2019, presso la sede dell'Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: \"Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law\".","twitter_image":"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/La-Dr.ssa-Cristaldi-di-PGA-interviene-al-convegno-Overview-on-patentability-requirements-of-pharma-inventions.jpg","twitter_misc":{"Written by":"PGA","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/","url":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/","name":"[:it]La Dr.ssa Cristaldi di PGA interviene al convegno \"Overview on patentability requirements of pharma inventions\"[:en]Dr. Cristaldi from PGA speaks at the conference \"Overview on patentability requirements of pharma inventions\"[:] - PGA Intellectual Property - Patents, Trademarks &amp; Designs","isPartOf":{"@id":"https:\/\/pga-ip.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage"},"image":{"@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage"},"thumbnailUrl":"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg","datePublished":"2019-11-18T13:37:49+00:00","author":{"@id":"https:\/\/pga-ip.com\/#\/schema\/person\/b4d457f38b2d14ac039d12aebbcf73a7"},"description":"Il 2 ottobre 2019, presso la sede dell'Ordine dei Consulenti in Propriet\u00e0 Industriale a MILANO, si \u00e8 tenuto un convegno dal titolo: \"Overview on World Wide patentability requirements of pharma inventions - with special focus on India Patent Law\".","breadcrumb":{"@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#primaryimage","url":"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg","contentUrl":"https:\/\/pga-ip.com\/wp-content\/uploads\/2019\/11\/hans-reniers-lQGJCMY5qcM-unsplash.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/pga-ip.com\/en\/2019\/11\/18\/la-dr-ssa-cristaldi-di-pga-interviene-al-convegno-overview-on-patentability-requirements-of-pharma-inventions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pga-ip.com\/"},{"@type":"ListItem","position":2,"name":"Dr. Cristaldi from PGA speaks at the conference &#8220;Overview on patentability requirements of pharma inventions&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/pga-ip.com\/#website","url":"https:\/\/pga-ip.com\/","name":"PGA Intellectual Property - Patents, Trademarks &amp; Designs","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pga-ip.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pga-ip.com\/#\/schema\/person\/b4d457f38b2d14ac039d12aebbcf73a7","name":"PGA","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pga-ip.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ca59aaf858c703dba8561c87a406e7dd25e9a31bd6d06a1de9ce919401cae3c4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca59aaf858c703dba8561c87a406e7dd25e9a31bd6d06a1de9ce919401cae3c4?s=96&d=mm&r=g","caption":"PGA"},"url":"https:\/\/pga-ip.com\/en\/author\/pga\/"}]}},"_links":{"self":[{"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/posts\/72653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/comments?post=72653"}],"version-history":[{"count":0,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/posts\/72653\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/media\/72654"}],"wp:attachment":[{"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/media?parent=72653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/categories?post=72653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pga-ip.com\/en\/wp-json\/wp\/v2\/tags?post=72653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}